Get Started

ASPE

NASD Aspen Neuroscience, Inc.
Nov 1, 2026 · 9:31 PM ET EOD Market Closed

$14.89 ↑ +0.00 (+0.00%) Trading Up from the previous close of $14.89, $0.01 below the day’s high of $14.90

YTD change
N/A
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$11.60 $14.90
open $14.70 close $14.89
+$0.19 (+1.29%)
Today
$11.60 $14.90
$14.89
Past week
$0.00 $0.00
$14.89
Past month
$0.00 $0.00
$14.89
This year
$11.60 $14.90
$14.89

Price & Performance

+0.00 (+0.00%) / 6M

No chart data available

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A

No sentiment data available for ASPE.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.656
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$72.4M
Debt$348.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $433.0M

Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne F. Loring and Andrés Bratt-Leal in 2018 and is headquartered in San Diego, CA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.